FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $47,938 | -93.4% | 10,071 | -85.9% | 0.03% | -93.1% |
Q4 2022 | $721,647 | -55.8% | 71,521 | -1.7% | 0.48% | -52.4% |
Q3 2022 | $1,631,000 | -4.3% | 72,766 | +5.8% | 1.01% | -3.4% |
Q2 2022 | $1,705,000 | -23.9% | 68,793 | +19.0% | 1.04% | -13.4% |
Q1 2022 | $2,241,000 | -21.2% | 57,808 | +18.9% | 1.20% | -20.5% |
Q4 2021 | $2,844,000 | -1.8% | 48,603 | -0.5% | 1.52% | +13.6% |
Q3 2021 | $2,895,000 | -32.9% | 48,838 | -1.7% | 1.33% | -38.2% |
Q2 2021 | $4,312,000 | +11.9% | 49,685 | +6.3% | 2.16% | -2.1% |
Q1 2021 | $3,855,000 | -2.5% | 46,755 | +7.6% | 2.21% | -19.7% |
Q4 2020 | $3,953,000 | +132.4% | 43,468 | +13.6% | 2.75% | +114.5% |
Q3 2020 | $1,701,000 | – | 38,263 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |